Search hospitals > Pennsylvania > Allentown
Saint Luke's Cancer Center - Allentown
Claim this profileAllentown, Pennsylvania 18104
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Tumors
Conducts research for Non-Small Cell Lung Cancer
14 reported clinical trials
8 medical researchers
Summary
Saint Luke's Cancer Center - Allentown is a medical facility located in Allentown, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Adenocarcinoma, Tumors, Non-Small Cell Lung Cancer and other specialties. Saint Luke's Cancer Center - Allentown is involved with conducting 14 clinical trials across 47 conditions. There are 8 research doctors associated with this hospital, such as Darius Desai, Neil D. Belman, Melissa A. Wilson, and Sheikh Asim Ali.Area of expertise
1Cancer
Stage IV
ROS1 positive
KRAS positive
2Lung Cancer
Stage IV
Stage II
Stage I
Top PIs
Darius DesaiSt Luke's University Health Network, Anderson Campus3 years of reported clinical research
Studies Pancreatic Cancer
Studies Pancreatic Cyst
4 reported clinical trials
11 drugs studied
Neil D. BelmanSaint Luke's University Hospital-Bethlehem Campus9 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
4 reported clinical trials
8 drugs studied
Melissa A. WilsonSt. Lukes University Health Network5 years of reported clinical research
Studies Melanoma
Studies Cancer
4 reported clinical trials
7 drugs studied
Sheikh Asim AliSaint Luke's University Hospital-Bethlehem Campus6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
3 reported clinical trials
11 drugs studied
Clinical Trials running at Saint Luke's Cancer Center - Allentown
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Ovarian Cancer
Fallopian Tube Cancer
Breast Cancer
Peritoneal Cancer
Colorectal Cancer
Cancer
Tumors
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Stereotactic Radiosurgery vs Whole-Brain Radiotherapy
for Brain Metastasis from Lung Cancer
This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.
Recruiting2 awards Phase 315 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Luke's Cancer Center - Allentown?
Saint Luke's Cancer Center - Allentown is a medical facility located in Allentown, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Adenocarcinoma, Tumors, Non-Small Cell Lung Cancer and other specialties. Saint Luke's Cancer Center - Allentown is involved with conducting 14 clinical trials across 47 conditions. There are 8 research doctors associated with this hospital, such as Darius Desai, Neil D. Belman, Melissa A. Wilson, and Sheikh Asim Ali.